Stelvio Therapeutics Company
Stelvio Oncology is focused on delivering precision medicine diagnostics and novel therapeutics for glioblastoma.
Technology:
Personalised Medicine
Industry:
P4 Medicine
Headquarters:
Others
Funding Status:
Seed
Investors Number:
2
Estimated Revenue:
Less than $1M
Last Funding Type:
Seed
Register and Claim Ownership